Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $52483.0.

  • KORU Medical Systems' Capital Expenditures fell 9515.67% to $52483.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $481168.0, marking a year-over-year decrease of 6869.53%. This contributed to the annual value of $1.3 million for FY2024, which is 6571.03% up from last year.
  • KORU Medical Systems' Capital Expenditures amounted to $52483.0 in Q3 2025, which was down 9515.67% from $28814.0 recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Capital Expenditures ranged from a high of $1.2 million in Q2 2022 and a low of -$43567.0 during Q4 2024
  • Its 5-year average for Capital Expenditures is $300649.7, with a median of $149497.0 in 2021.
  • In the last 5 years, KORU Medical Systems' Capital Expenditures skyrocketed by 195191.73% in 2022 and then crashed by 12222.22% in 2024.
  • Over the past 5 years, KORU Medical Systems' Capital Expenditures (Quarter) stood at $44458.0 in 2021, then skyrocketed by 393.42% to $219363.0 in 2022, then dropped by 10.63% to $196052.0 in 2023, then tumbled by 122.22% to -$43567.0 in 2024, then skyrocketed by 220.47% to $52483.0 in 2025.
  • Its Capital Expenditures was $52483.0 in Q3 2025, compared to $28814.0 in Q2 2025 and $443438.0 in Q1 2025.